25 results
Hypoxemia and Dyspnea - Rapid Response Management

1) Ask for vitals en route
2) Stabilize: Nasal canula 
3)
Management 1) Ask ... ) Examination: Pulmonary ... the underlying cause ... Dyspnea #Management #criticalcare ... #pulmonary #Hypoxia
Balloon Visualization - Mechanical Ventilation Pressures - PIP, PPlat, PEEP

Peak Inspiratory Pressure (PIP): Dynamic pressure needed
) Inspiratory Pause ... #PPlat #PEEP #CriticalCare ... Diagnosis #Balloon #Pathophysiology ... #Pulmonary
Shock Classification Types - Pathophysiology Comparison

Obstructive Shock:
 • Obstructive shock is characterized by a blockage in
Classification Types - Pathophysiology ... in blood flow caused ... Depends on the cause ... Pulmonary embolism ... #Comparison #criticalcare
Bronchiectasis - Summary

What?
• Bronchiectasis is derived from the Greek words bronckos meaning airway and ectasis meaning
Chronic inflammation causes ... Most Common Causes ... Broncho-arterial ratio (BAR ... ) - BAR >1.0 is ... mycobacteria Treatment
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
Pulmonary Renal ... Goodpasture's cause ... • BAL reveals ... hematuria, RBC casts ... diagnosis #management #treatment
Oxygen Delivery by Device

Nasal Cannula 
• Indicated for low-flow, low-percentage supplemental oxygen. 
• Flow rate of
use of reservoir bag ... retention of exhaled gases ... Venturi Mask (venti-mask ... • Uses either ... Delivery #FiO2 #Pulmonary
Widened Pulse Pressure - Differential Diagnosis and Pathophysiology

Pulse pressure is the difference between the systolic blood
Diagnosis and Pathophysiology ... disorders - Chronic pulmonary ... • Mitchell et al ... Infarction • Pulmonary ... Differential #Diagnosis #Pathophysiology
Massive Hemoptysis - Diagnosis and Management
 • Definitions: 
   - Hemoptysis = bleeding from
has potential to cause ... Diagnosis #Management #treatment ... #workup #pulmonary ... #criticalcare
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
blood donor • Pathophysiology ... without other cause ... : 33% • Treatment ... , and CXR with pulmonary ... : No • Treatment
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
starting amiodarone treatment ... Exclude other causes ... macrophages in the BAL ... ↑ ESR, CRP BAL ... macrophages Treatment